Neurobiological Technologies Submits Hong Kong Stock Exchange Listing Application on June 25

According to Hong Kong Exchanges and Clearing disclosure on June 25, Neurobiological Technologies Limited (neurobiological pharma company) submitted a listing application to the Hong Kong Stock Exchange Main Board, with J.P. Morgan, CITIC Securities, and HSBC serving as joint sponsors. The company operates as a clinical-value-oriented specialty pharmaceutical platform focused on neurology, pain management, and allergy treatment in China, leveraging integrated research, manufacturing, and commercialization capabilities.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments